JP2003513034A5 - - Google Patents

Download PDF

Info

Publication number
JP2003513034A5
JP2003513034A5 JP2001534359A JP2001534359A JP2003513034A5 JP 2003513034 A5 JP2003513034 A5 JP 2003513034A5 JP 2001534359 A JP2001534359 A JP 2001534359A JP 2001534359 A JP2001534359 A JP 2001534359A JP 2003513034 A5 JP2003513034 A5 JP 2003513034A5
Authority
JP
Japan
Prior art keywords
cells
subject
called
transplantation
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001534359A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003513034A (ja
JP4846151B2 (ja
Filing date
Publication date
Priority claimed from DE19953517A external-priority patent/DE19953517C1/de
Application filed filed Critical
Publication of JP2003513034A publication Critical patent/JP2003513034A/ja
Publication of JP2003513034A5 publication Critical patent/JP2003513034A5/ja
Application granted granted Critical
Publication of JP4846151B2 publication Critical patent/JP4846151B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001534359A 1999-11-05 2000-11-03 骨髄もしくは血液幹細胞の移植前の患者のコンディショニングのためのトレオスルファンの使用 Expired - Fee Related JP4846151B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19953517.5 1999-11-05
DE19953517A DE19953517C1 (de) 1999-11-05 1999-11-05 Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation
PCT/EP2000/010871 WO2001032154A2 (de) 1999-11-05 2000-11-03 Verwendung von treosulfan zur konditionierung von patienten vor knochenmarktransplantation oder blutstammzelltransplantation

Publications (3)

Publication Number Publication Date
JP2003513034A JP2003513034A (ja) 2003-04-08
JP2003513034A5 true JP2003513034A5 (cg-RX-API-DMAC7.html) 2011-10-13
JP4846151B2 JP4846151B2 (ja) 2011-12-28

Family

ID=7928187

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001534359A Expired - Fee Related JP4846151B2 (ja) 1999-11-05 2000-11-03 骨髄もしくは血液幹細胞の移植前の患者のコンディショニングのためのトレオスルファンの使用

Country Status (16)

Country Link
US (1) US7199162B1 (cg-RX-API-DMAC7.html)
EP (1) EP1227808B1 (cg-RX-API-DMAC7.html)
JP (1) JP4846151B2 (cg-RX-API-DMAC7.html)
AT (1) ATE251455T1 (cg-RX-API-DMAC7.html)
AU (1) AU777527B2 (cg-RX-API-DMAC7.html)
BG (1) BG65845B1 (cg-RX-API-DMAC7.html)
CA (1) CA2389896C (cg-RX-API-DMAC7.html)
CZ (1) CZ299701B6 (cg-RX-API-DMAC7.html)
DE (2) DE19953517C1 (cg-RX-API-DMAC7.html)
EA (1) EA004543B1 (cg-RX-API-DMAC7.html)
ES (1) ES2208435T3 (cg-RX-API-DMAC7.html)
HU (2) HU227332B1 (cg-RX-API-DMAC7.html)
NO (2) NO329616B1 (cg-RX-API-DMAC7.html)
PL (1) PL212132B1 (cg-RX-API-DMAC7.html)
UA (1) UA73961C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001032154A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237146A1 (de) * 2002-08-13 2004-03-04 Medac Gesellschaft für klinische Spezialpräparate mbH Verwendung von Treosulfan und Derivaten davon zur Behandlung der Multiplen Sklerose
JP7431815B2 (ja) * 2018-09-26 2024-02-15 メダック ゲゼルシャフト フィア クリニッシェ スペツィアルプレパラーテ ミット ベシュレンクタ ハフトゥンク トレオスルファンの結晶形
PT4257122T (pt) 2018-09-26 2026-06-08 Medac Ges Fr Klinische Spezialprparate Mbh Liofilizado de treossulfano
EP3856252A1 (en) 2018-09-26 2021-08-04 medac Gesellschaft für klinische Spezialpräparate mbH Solution comprising treosulfan

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
DE4421391C1 (de) * 1994-06-18 1995-11-30 Gsf Forschungszentrum Umwelt Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression
WO2000045842A2 (en) * 1999-02-04 2000-08-10 The General Hospital Corporation Methods for human allografting

Similar Documents

Publication Publication Date Title
CA2387542A1 (en) Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation
GEP20032976B (en) Artificial Peptides Having Surface Activity and Use Thereof in The Preparation of Artificial Surfactant
DK1699915T3 (da) Anvendelse af erythropoietin til levervævsregenerering
DE69836822D1 (de) Verfahren zur Behandlung von Kapseln und trockenen gepulverten pharmazeutischen Formulierungen
SG146666A1 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
WO2007024441A3 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
CA2416492A1 (en) Treatment of glycogen storage disease type ii
HK1052301A1 (zh) α(2)巨球蛋白与抗原分子的复合物作免疫治疗用途
HUS1900041I1 (hu) Treoszulfán alkalmazása betegek csontvelõ- és vér õssejt-transzplantáció elõtti kondicionálására
Satilmis et al. Adipose-derived stem cells in the treatment of hepatobiliary diseases and sepsis
AP1896A (en) The method of treating cancer
JP2002171966A5 (cg-RX-API-DMAC7.html)
ATE297217T1 (de) Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
DE60033840D1 (de) Antisense-zusammensetzungen und verfahren zur behandlung von krebs
EP1211311A3 (en) Cord blood-derived activated lymphocytes and preparations containing said lymphocytes
JP2002534393A5 (cg-RX-API-DMAC7.html)
DK0652943T3 (da) Hæmatopoietiske, fremmende celler og anvendelse deraf
MXPA03001644A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MD1005G2 (ro) Procedeu de obţinere a cărbunilor activi
Zhong et al. LONG-TERM LIMB ALLOGRAFT SURVIVAL USING A SHORT COURSE OF ANTI-CD45RB MONOCLONAL ANTIBODY, LF15-0195 AND RAPAMYCIN IN A MOUSE MODEL.
Ren et al. Co-transplantation of umbilical cord blood mesenchymal stem cells and haploidentical hematopoietic stem cells for treatment of severe aplastic anemia
RU2000124826A (ru) Способ лечения больных с затяжной пневмонией
Plett et al. Homing of primitive hematopoietic cells in non-myeloablated murine recipients
NZ512123A (en) Isolated material having an anti-organotrophic effect where the material is purified from prepared ovarian venous plasma
Bug et al. Stem cell and cord blood transplantation–state of the art